tiprankstipranks
Advertisement
Advertisement

NTRA Stock Latest News

Natera’s New ctDNA-Guided Immunotherapy Trial Could Redefine Cancer Treatment Cycles
Company AnnouncementsNatera’s New ctDNA-Guided Immunotherapy Trial Could Redefine Cancer Treatment Cycles
6d ago
NTRA
Natera reports results from multicenter study in MCC
PremiumThe Fly
Natera reports results from multicenter study in MCC
9d ago
NTRA
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
PremiumTipRanks Newswire
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
14d ago
GH
JTAI
Natera price target raised to $325 from $280 at TD Cowen
PremiumThe Fly
Natera price target raised to $325 from $280 at TD Cowen
15d ago
NTRA
Natera price target raised to $330 from $285 at Canaccord
PremiumThe Fly
Natera price target raised to $330 from $285 at Canaccord
17d ago
NTRA
Natera price target raised to $310 from $250 at Morgan Stanley
PremiumThe FlyNatera price target raised to $310 from $250 at Morgan Stanley
22d ago
NTRA
Natera announces IVDR certification for Signatera
Premium
The Fly
Natera announces IVDR certification for Signatera
22d ago
NTRA
Natera Announces Board Resignation Amid Governance Transition
Premium
Company Announcements
Natera Announces Board Resignation Amid Governance Transition
24d ago
8K
NTRA
Natera price target raised to $300 from $270 at Evercore ISI
PremiumThe Fly
Natera price target raised to $300 from $270 at Evercore ISI
24d ago
NTRA
Natera announces publication evaluating utility of Signatera
PremiumThe Fly
Natera announces publication evaluating utility of Signatera
25d ago
NTRA
Natera price target raised to $290 from $270 at Guggenheim
PremiumThe Fly
Natera price target raised to $290 from $270 at Guggenheim
1M ago
NTRA
Natera, Aveta Biomics announce strategic partnership
PremiumThe Fly
Natera, Aveta Biomics announce strategic partnership
1M ago
NTRA
Natera resumed with an Outperform at Bernstein
PremiumThe FlyNatera resumed with an Outperform at Bernstein
1M ago
NTRA
Natera: Japan Signatera Opportunity Balanced by Valuation; Hold Rating Reiterated, $245 Price Target Maintained
Premium
Ratings
Natera: Japan Signatera Opportunity Balanced by Valuation; Hold Rating Reiterated, $245 Price Target Maintained
1M ago
NTRA
Natera, Eledon announce strategic partnership
Premium
The Fly
Natera, Eledon announce strategic partnership
1M ago
ELDN
NTRA
Natera price target raised to $275 from $270 at BTIG
PremiumThe Fly
Natera price target raised to $275 from $270 at BTIG
1M ago
NTRA
Natera announces Signatera receives regulatory approval in Japan
PremiumThe Fly
Natera announces Signatera receives regulatory approval in Japan
1M ago
NTRA
Natera price target lowered to $260 from $280 at Barclays
PremiumThe Fly
Natera price target lowered to $260 from $280 at Barclays
1M ago
NTRA
NCCN recommends ctDNA-MRD testing using Signatera technology
PremiumThe Fly
NCCN recommends ctDNA-MRD testing using Signatera technology
1M ago
NTRA
Natera price target raised to $270 from $250 at BTIG
PremiumThe FlyNatera price target raised to $270 from $250 at BTIG
1M ago
NTRA
NCCN guidelines may be meaningful catalyst for Natera, says Leerink
Premium
The Fly
NCCN guidelines may be meaningful catalyst for Natera, says Leerink
1M ago
NTRA
AI Models Split on Natera (NTRA) as Growth Momentum Meets Valuation Risk
Premium
AI Analyst Ratings
AI Models Split on Natera (NTRA) as Growth Momentum Meets Valuation Risk
1M ago
NTRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >